The LMP Research Conference (LMPRC) 2025
A day where we celebrate and share the research conducted in the Department of Laboratory Medicine and Pathobiology.
The day usually consists of:
-
Graduate student poster presentations
-
Postgraduate research poster presentations
-
Winning LMP 3-minute thesis competition presentation
-
A keynote speaker - topic TBC
-
Workshops on skills and techniques
-
Lots of networking
When and where
Thursday, April 17, 2025 all day
The Arcadian,
401 Bay Street, Simpson Tower 8th floor, Toronto, ON M5H 2Y4
How to register
Save the date! Registration will open in January 2025.
If you have any questions, contact us at lmp.rc@utoronto.ca.
Important dates
- January 7, 2025: abstract submission and registration opens
- 19 February, 2025: abstract submissions close
- 20 March, 2025 (approx): oral presenters will be announced
- 1 April, 2025: registration closes
Information for graduate students and postgraduate trainees: abstract submissions
Who should submit an abstract and how
Abstract submission will be open January 7 - February 19, 2025.
All graduate and postgraduate learners in LMP are invited to present a poster at the conference.
It is compulsory for the following graduate students to submit an abstract:
- Second-year MSc students
- Second- and fourth-year PhD students
- Second-year Translational Research Program students (capstone project presentations)
Not compulsory, but strongly encouraged:
- Second-year MHSc in Laboratory Medicine students (capstone project presentations)
Postgraduates in LMP are required to submit abstracts and present a poster as below:
- PGY2, PGY3, and PGY5 Diagnostic and Molecular Pathology residents
- PGY2, PGY3, PGY4 Hematopathology residents
- Medical Microbiology residents and all Clinical Microbiology trainees - you must present your research with you as the presenter/co-presenter of your work at least once during your training
Not compulsory, but strongly encouraged:
- Clinical Chemistry trainees
- Neuropathology residents
- all other LMP residents/trainees – we encourage you to present
All LMP residents/trainees must attend regardless as to whether they are presenting research.
Abstract submission will open in January 2025.
Abstract specifics
Abstracts:
- should be no more than 500 words
- should not include figures or graphics
- may be structured or unstructured, depending on the stage of your research
Preparing for your poster or oral presentation: resources
Do you want help practicing your poster presentation? Contact the Peer Communication Team and access expert coaching and feedback on your presentation.
Poster boards are typically 48 inches tall by 94 inches wide. The poster dimensions should be no greater than 44 inches x 91 inches. You are limited to this surface, however, you do not need to fill the entire board. The recommended minimum size is 42 inches x 68 inches.
Templates
Download PowerPoint and Publisher templates from LMP
See also:
- Free Research Poster PowerPoint Templates from posterpresentations.com
- Scientific Poster PowerPoint Templates from Make Signs
- Free PowerPoint research poster templates in various sizes and styles from Genigraphics
And from the School of Graduate Studies
- Design of Scientific Posters, Michael Alley, Penn State University
- Advice on Designing Scientific Posters, Colin Purrington, Swarthmore College
- Poster Presentation Guidelines, Varinder K. Randhawa and Philip J. Bilan
- Creating Effective Poster Presentations, George R. Hess, Kathryn W. Tosney, and Leon H. Liegel
Keynote speaker: Dr. Michael Laflamme
Dr. Michael Laflamme is the Robert McEwen Chair in Cardiac Regenerative Medicine, Canada Research Chair (Tier 1) in Cardiovascular Regenerative Medicine, Senior Scientist in the McEwen Stem Cell Institute, Staff Pathologist in the Laboratory Medicine Program at the University Health Network (UHN), and Professor of Laboratory Medicine & Pathobiology at the University of Toronto.
He leads a research program that is focused on developing novel cardiac cell therapies based on human pluripotent stem cells (hPSCs), and his laboratory has made a number of important contributions in this area including efficient protocols to guide hPSCs into cardiomyocytes, proof-of-concept transplantation studies with hPSC-derived cardiomyocytes in preclinical models, and the first direct demonstration that hPSC-derived cardiomyocytes can become electrically integrated and activate synchronously with host myocardium in injured hearts.
Dr. Laflamme has been the recipient of honors including the Society for Cardiovascular Pathology Young Investigator Award, the American Society of Gene & Cell Therapy Outstanding New Investigator Award, and the UHN Inventor of the Year.
He also practices cardiovascular and autopsy pathology and is a founding investigator of BlueRock Therapeutics. Read more in A 20 year path to translation: repairing broken hearts.
